Allergy Therapeutics PLC
LSE:AGY
Allergy Therapeutics PLC
LSE:AGY
Price:
8.9
GBX
2.3%
Market Closed
Market Cap:
£563.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Allergy Therapeutics PLC
LSE:AGY
|
UK |
|
Resaas Services Inc
XTSX:RSS
|
CA |
|
N
|
Netweb Technologies India Ltd
NSE:NETWEB
|
IN |
|
Crescita Therapeutics Inc
TSX:CTX
|
CA |
|
Turquoise Hill Resources Ltd
TSX:TRQ
|
CA |
|
L
|
Lion Rock Resources Inc
XTSX:ROAR
|
CA |
|
Empire State Realty Trust Inc
NYSE:ESRT
|
US |
|
Axe Compute Inc
NASDAQ:AGPU
|
US |
Wall St Price Targets
AGY Price Targets Summary
Allergy Therapeutics PLC
Allergy Therapeutics PLC
Wall Street analysts forecast AGY stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for AGY is 13.26 GBX with a low forecast of 13.13 GBX and a high forecast of 13.65 GBX.
Lowest Forecast
Price Target
13.13
GBX
48% Upside
Average Forecast
Price Target
13.26
GBX
49% Upside
Highest Forecast
Price Target
13.65
GBX
53% Upside
Allergy Therapeutics PLC Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AGY's stock price target?
Price Target
13.26
GBX
13.26
GBX
According to Wall Street analysts, the average 1-year price target for AGY is 13.26 GBX with a low forecast of 13.13 GBX and a high forecast of 13.65 GBX.
What is the Revenue forecast for Allergy Therapeutics PLC?
Projected CAGR
18%
18%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 1 year is 18%.
